• Wed news: BioNTech buying Biotheus. FDA’s Califf lists hopes for his successor. Amgen loses $12B market cap from hidden spreadsheet tab. TRex Bio raises $84M. London is Europe’s life science capitol. See more on our front page

Good Bye Dan, Welome Back Joerg! What's have you brought us back?

Anonymous

Guest
I would be very surprised if Joerg Reinhardt came back empty-handed after his stint at Bayer. Will he bring the whole shop? We have been there before in 2007 and 2010...
 








The (in)famous (former) Head (Dictator) of Pharma HR, Neil Anthony, is now (Head of nothing) working on "Special Projects".

It's like the Arab Spring in the Middle East . . . . . . but with fewer mustaches! And unfortunately, they will not end up like Gaddafi with a pistol barrel stuck up their anus!
 




With any luck he will bring closure to Jimenes and all those shit-for-Brains MBAs and bring the company back to science, research and product development

i think that he should keep Jimenez around long enough to increase the efforts to reduce and then rid us, as much as possible of, sales and marketing!
 








Dan knows the shits about to hit the fan , especially selling to terrorist countries .
"Novartis: U.S. Probing Export of Alcon Products to Iran, Other Trade-Sanction Countries"

Plus all the other looming scandels so he pulled a hillary clinton